CTRI/2022/03/041314RecruitingPhase 4
Vellore Typhoid Vaccine Impact Trial
Christian Medical College Vellore0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 4
- Status
- Recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Provide written informed consent
- •Residents of study area
Exclusion Criteria
- •Has received a typhoid vaccine in the previous three years
- •Is known to have an allergy to any vaccine component
- •Pregnancy or planning pregnancy around vaccination
- •Receipt of any other vaccine in the past 30 days (temporary exclusion)
- •Febrile illness in the 24 hours before vaccination (temporary exclusion)
Investigators
Similar Trials
Active, not recruiting
Not Applicable
Fluval AB Vaccine Serologic Clinical TrialImmunization of healthy people against influenza virus infections.EUCTR2004-001600-12-HUOMNINVEST Kft.
Active, not recruiting
Phase 1
Pneumococcal vaccine against atherosclerosisHealthy male volunteersMedDRA version: 19.0Level: LLTClassification code 10003601Term: AtherosclerosisSystem Organ Class: 100000004866EUCTR2015-005650-35-NLCentre for Human Drug Research24
Completed
Phase 2
Proof-of-pharmacology clinical trial on a vaccine that elicits a protective humoral immune response against oxidized low density lipoproteiHypercholesterolemie10003216AtherosclerosisNL-OMON43410Centre for Human Drug Research24
Completed
Phase 4
Vellore Typhoid Vaccine Impact TrialTyphoid FeverNCT05500482Christian Medical College, Vellore, India72,400
Recruiting
Phase 2
Effects of vaccinium arctostaphylos fruit on cardiometabolic indices in hypertensive obese patientsCondition 1: Obesity. Condition 2: Hypertension.Obesity due to excess caloriesEssential (primary) hypertensionIRCT201710302288N12Vice Chancellor for Research, Research Institute for Islamic and Complementary Medicine100